Biotechnology Press Release
|05/11/2020 - 14:32||
Ritter Pharmaceuticals Regains Compliance with Nasdaqs Stockholders Equity Requirement for Continued Listing
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing.
|05/11/2020 - 12:56||
TRODELVY (sacituzumab govitecan-hziy), FDA Approved for Treatment of Metastatic Triple-negative Breast Cancer, Available Only at Biologics by McKesson
CARY, N.C., May 11, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Immunomedics, Inc.
|05/11/2020 - 11:43||
Scientific coalition developing surveillance system for detecting emerging pandemics in real-time
The Sentinel system, which is first being applied in West Africa, will combine genomics with information technology to detect and contain known and new threats such as COVID-19
|05/11/2020 - 11:35||
CTI Partners with Pulmotect on Two Phase-2 Trials Targeting COVID-19
FOR IMMEDIATE RELEASE [Covington, KY ~ May 11, 2020] – CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, is partnering with Pulmotect, Inc., a clinical-stage biotechnology company, on two COVID-19 phase 2 clinical trials of Pulmotect’s innate immune stimulating drug PUL-042, entitled:
|CTI Clinical Tr...|
|05/11/2020 - 11:12||
Fred Hutch, NIH experts outline plan for COVID-19 vaccines
In a Science perspective, experts urge multi-pronged, coordinated approach to successfully develop COVID-19 vaccines.
|05/11/2020 - 10:01||
An interdisciplinary team of researchers at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA has developed a first-of-its-kind roadmap of how human skeletal muscle develops, including the formation of muscle stem ce
The study, published May 11 in the peer-reviewed journal Cell Stem Cell, identified various cell types present in skeletal muscle tissues, from early embryonic development all the way to adulthood. Focusing on muscle progenitor cells, which contribute to muscle formation before birth, and muscle stem cells, which contribute to muscle formation after birth and to regeneration from injury throughout life, the group mapped out how the cells’ gene networks — which genes are active and inactive — change as the cells mature.
|05/11/2020 - 09:53||
Myriad Receives FDA Approval of myChoice CDx as Companion Diagnostic for Lynparza (olaparib) In Patients with Advanced Ovarian Cancer
Lynparza (olaparib) is a novel PARP inhibitor jointly developed and commercialized by AstraZeneca (LSE/STO/NYSE: AZN) and Merck, known as MSD outside of the U.S. and Canada.
|05/11/2020 - 07:46||
BioMarin Announces Proposed Private Offering of $500 Million of Senior Subordinated Convertible Notes
BioMarin also intends to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $50.0 million aggregate principal amount of notes.
|05/11/2020 - 07:33||
Ampio Reports Acceptance of Publication on the Potential Benefits of Nebulized Ampion for COVID-19 Patients
The manuscript titled, “The novel immunomodulatory biologic LMWF5A (Ampion) for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis”, provides a detailed description of the biochemical and immunological phenomena collectively termed the “cytokine storm” encountered in COVID-19 patients and evaluates the potential benefit of Ampion treatment for these patients. A link to the publication will be provided on the company’s website once available.
|05/11/2020 - 06:11||
BioMarin Announces Pricing of Upsized $550 Million Senior Subordinated Convertible Notes Offering
The aggregate principal amount of the offering was increased from the previously announced offering size of $500.0 million. BioMarin also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $50.0 million aggregate principal amount of notes. The sale of the notes is expected to close on May 14, 2020, subject to customary closing conditions.
|05/11/2020 - 02:41||
Automotive Wiring Harness Market Report 2020, Covid-19 Impact, Market Trends, Share, Size & Forecast Till 2025
According to the latest report by IMARC Group titled, “Automotive Wiring Harness Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global automotive wiring harness market grew at a CAGR of around 6% during 2014-2019.
|05/09/2020 - 19:33||
Coronavirus (COVID-19) Update: FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients
The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.
|05/08/2020 - 13:47||
Reopening America, China's 'Mask Diplomacy,' State Police Powers: RAND Weekly Recap
This week we discuss a new RAND tool that estimates the effects of rolling back or maintaining social distancing and other disease-fighting measures; how China is trying to distract from its role in the pandemic; state police powers and COVID-19; protecting food workers and volunteers; the looming rental housing crisis; and using rideshares to provide non-emergency medical transportation.
|05/08/2020 - 13:01||
From astronaut to economist, the Alltech ONE Virtual Experience announces stellar keynote lineup
The Alltech ONE Virtual Experience will offer on-demand insights from leading experts in agriculture and beyond, beginning May 18, 2020.
|05/08/2020 - 09:57||
Scottish funding supports Roslin Covid-19 work
Research on the transmission of the coronavirus, critical aspects of the disease and 3D printing of bespoke PPE receive Scottish Government funding.
|05/08/2020 - 09:47||
Lupins Pithampur Facilities Complete Successful UK MHRA Inspection
Mumbai, India, May 8, 2020: Pharma major Lupin Limited (Lupin) today announced the successful close out of the inspection carried out by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK), at its three manufacturing units in Pithampur (India). The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020.
|05/08/2020 - 08:31||
Data method seeks weak spots in coronavirus DNA
Machine learning algorithms can identify areas of coronavirus genetic makeup that could be the focus of potential treatments.
|05/08/2020 - 01:19||
Sorrento And Mount Sinai Health System To Jointly Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19)
Carlos Cordon-Cardo , MD, PhD, Irene Heinz Given and John LaPorte Given Professor and Chair of Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai and his team screened approximately fifteen thousand individuals who may have had and recovered from COVID-19 for the presence of anti-COVID-19 antibodies.
|05/08/2020 - 00:12||
GlycoMimetics Announces Change to Virtual Meeting Format for 2020 Annual Meeting of Shareholders
Due to the ongoing public health impact of the COVID-19 pandemic and to support the health and well-being of the Company’s stockholders, employees and their families, the Company will hold the Annual Meeting via live audio webcast rather than as an in-person meeting. The virtual Annual Meeting is expected to provide stockholders with the same rights and opportunities to participate as they would have at an in-person meeting. As previously announced, the Annual Meeting will be held on Friday, May 22, 2020 at 9:00 a.m.
|05/07/2020 - 15:57||
ANU Socially Responsible Investment Report 2019
The Australian National University adopted a Socially Responsible Investment (SRI) Policy in July 2013. This policy contained clear Environmental, Social and Governance (ESG) benchmarks, becoming at the time one of only a handful of Universities worldwide who use responsible investment to advance its objectives on social and sustainability issues.
|05/07/2020 - 15:24||
Scientists at Gladstone and UCSF launch new efforts in virology and genomic immunology
Gladstone Celebrates is an event held annually to recognize individuals who have made extraordinary contributions to Gladstone’s community and outstanding scientific achievements.
|05/07/2020 - 11:56||
Research Brief: Ethics around businesses marketing unproven and unlicensed COVID-19 stem-cell-based therapies
A scientist doing a cell culture experiment in a cleanroom facility. Photo credit: Manjurul on Getty Images.
|05/07/2020 - 11:54||
BIOCLINICA ANNOUNCES COMPREHENSIVE COVID-19 CLINICAL ENDPOINT ADJUDICATION SOLUTION
PRINCETON, N.J., May 7, 2020 – Bioclinica, a leading provider of clinical science and technology expertise to assist the life science industry, today announced a specialized program for the adjudication of adverse events that could result from COVID-19 infection.
|05/07/2020 - 10:32||
Applied BioMath, LLC Provides Systems Pharmacology Model to Support Fibrinolytic Therapy for Refractory COVID-19 Acute Respiratory Distress Syndrome
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced that it is creating a systems pharmacology model to support ongoing research into the compassionate care use of tissue plasminogen activator (tPA) as treatment of respiratory distress for patients with Acute Respiratory Distress Syndrome (ARDS) due to COVID-19, for whom ventilators do not work, or for those without ventilators.
|05/07/2020 - 10:22||
CoVIg-19 Plasma Alliance Builds Strong Momentum Through Expanded Membership and Clinical Trial Collaboration
Osaka, JAPAN, and King of Prussia, PA, USA - Rapidly expanding support for the Alliance is increasing donations of convalescent plasma to begin clinical production, while NIH collaboration confirms clinical trial approach - Alliance urges anyone who has recovered from COVID-19 to consider donating today.